Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30P H Naylor, C W Naylor, M Badamchian, et al.
Lancet (London, England)|September 7, 1985
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy AfricansR J Biggar, P L Gigase, M Melbye, et al.
Journal of Forensic Sciences|November 1, 1989
Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidenceP D Bigbee, P S Sarin, J C Humphreys, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
Pediatric Blood & Cancer|September 25, 2004
Health status of young children during therapy for advanced neuroblastomaP C Nathan, W Furlong, S De Pauw, et al.
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.
Lancet (London, England)|December 22, 1984
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USAM Melbye, K S Froebel, R Madhok, et al.
International Journal of Cancer|September 15, 1982
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphomaW A Blattner, V S Kalyanaraman, M Robert-Guroff, et al.
Pageof 21